awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34084724-128B0697-4A9B-4525-B657-D175869D0132
Q34084724-128B0697-4A9B-4525-B657-D175869D0132
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34084724-128B0697-4A9B-4525-B657-D175869D0132
Cetuximab as second-line therapy in patients with metastatic esophageal adenocarcinoma: a phase II Southwest Oncology Group Study (S0415)
P2860
Q34084724-128B0697-4A9B-4525-B657-D175869D0132
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34084724-128B0697-4A9B-4525-B657-D175869D0132
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b78ec6cb3e5ea9fc82b7c8230f648e5f979de373
P2860
Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines.